Summary
Updated Aug 31, 2026
Robin Kramer is Director of Armata Pharmaceuticals, Inc. (ARMP). 4 SEC Form 4 filings on record going back to 2024, most recently on 12 March 2026.
Recent Transactions
8Every recent SEC Form 4 transaction Robin Kramer has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Robin Kramer go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Robin Kramer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Priya Singhal - $735K of BIIB open-market activity in the last 12 months
- Lloyd Minor - $240K of BIIB open-market activity in the last 12 months
- Nicole Murphy - $585 of BIIB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Robin Kramer?
Robin Kramer is a corporate insider, tracked as Director of Armata Pharmaceuticals, Inc. (ARMP). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robin Kramer last file a Form 4?
The most recent primary Form 4 on record is dated 12 March 2026, one of 4 filings going back to 2024.
Where can I see all of Robin Kramer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Robin Kramer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial